Cannabis Use Disorder Clinical Trial
Official title:
Reaching and Motivating Change in Teen Marijuana Smokers
This study will test a behavioral intervention tailored for adolescents who smoke marijuana
and have concerns about their use. The study's purpose is to determine whether this
intervention (two-sessions of motivational enhancement intervention followed by 12 months of
optional skills training) will be more effective in reducing the use of this drug if
augmented by three periodic motivational enhancement treatment check-in sessions as compared
to three periodic computer-based check-in sessions.
HYPOTHESES: (1) Participants in the motivational enhancement treatment check-ins (MCI)
condition will reduce their use of marijuana more than participants in the computer based
(Comp) condition and report fewer negative consequences. These differences are expected to
be greater at later follow-ups (i.e, 9, 12, and 15 months) after repeated check-ins exert a
cumulative effect. (2)Engagement in CBT sessions will be greater for those in the MCI
condition and will partially mediate the effect on marijuana related outcome indices. (3)
The MCI intervention will lead to increased self-efficacy, and decreased normative
perceptions of marijuana use by other teens that will also partially mediate the effect of
the intervention.
The goal of this trial is to evaluate the efficacy of an enhanced Teen Marijuana Check-Up
protocol to reach and intervene with non-treatment seeking adolescents who use marijuana
heavily. Two hundred fifty adolescents who use marijuana heavily will receive a 2-session
individual motivational enhancement therapy. All participants will also be offered the
opportunity, over a 12-month period, to repeatedly re-initiate marijuana counseling.
Participants will be randomly assigned to receive one of two types of periodic follow-up
contacts: Motivational interviewing-based Marijuana Check-Ins (MCI) or Computer Based
Control (Comp) sessions.
All participants will be reassessed at the 6, 9, 12, and 15-month anniversaries of
enrollment. Following their initial motivational enhancement therapy, the 125 experimental
condition participants will additionally have a motivational enhancement treatment
"check-in" session with their counselor at the 4, 7, and 10-month anniversaries of
enrollment intended to reinforce the maintenance of treatment gains and motivate continued
success, increase motivation to change for participants who did not meet their marijuana use
goals, and/or prompt utilization of cognitive-behavioral treatment (CBT) sessions as needed.
The 125 comparison participants will complete a computer based questionnaire at the same
time intervals to serve as an attentional control.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05726617 -
Avatar Intervention for the Treatment of Cannabis Use Disorder in Patients With Severe Mental Health Disorders
|
N/A | |
Not yet recruiting |
NCT04139668 -
Vivitrol Treatment for Cannabis Use Disorder
|
Phase 2 | |
Completed |
NCT01656707 -
Adaptive Treatment for Adolescent Cannabis Use Disorders
|
N/A | |
Completed |
NCT03204305 -
Brain Imaging of Cannabinoid Receptors
|
Early Phase 1 | |
Completed |
NCT05005013 -
A Teleheath tDCS Approach to Decrease Cannabis Use
|
N/A | |
Recruiting |
NCT05292547 -
Repetitive Transcranial Magnetic Stimulation to People With Cannabis Use Disorder (SToP-C-rTMS x CUD)
|
N/A | |
Completed |
NCT02932215 -
Use of a Mobile Health Sensor in an Open Label Trial of Lorcaserin for the Treatment of Cannabis Use Disorder
|
Phase 1 | |
Completed |
NCT03430050 -
Progesterone for Cannabis Withdrawal
|
Early Phase 1 | |
Withdrawn |
NCT03629106 -
Effects of Cannabis Abstinence on Symptomology and Cognition in Bipolar Disorder
|
N/A | |
Completed |
NCT03334721 -
Gabapentin for Bipolar & Cannabis Use Disorders
|
Phase 2 | |
Recruiting |
NCT04721353 -
Reducing Cannabis Overuse With Prazosin
|
Phase 4 | |
Completed |
NCT03718520 -
The Influence of in Utero Cannabis Exposure on Neonatal Brain Morphology and Structural Connectivity
|
||
Completed |
NCT03624933 -
Effects of Cannabis Abstinence on Symptoms and Cognition in Depression
|
N/A | |
Recruiting |
NCT05836207 -
Rewards for Cannabis Abstinence-study
|
N/A | |
Not yet recruiting |
NCT06114212 -
Deep Repetitive Transcranial Magnetic Stimulation for Cannabis Use Disorder
|
N/A | |
Recruiting |
NCT05855668 -
Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment
|
N/A | |
Recruiting |
NCT04517474 -
Comparing the Spanish Version of CANreduce With or Without Psychological Support and Treatment as Usual, Reducing Cannabis Use.
|
N/A | |
Recruiting |
NCT05885542 -
SCORE Emerging Adult Cannabis Use & Stress
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06085222 -
Evaluation of a Brief Computerized and Smart Phone-based Intervention for Stress in Regular Cannabis Users
|
Phase 1 | |
Completed |
NCT03056482 -
Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC)
|
Phase 4 |